BOK official says monetary policy challenge deepens following Fed’s rate hike

SEOUL– A policymaker of the Bank of Korea (BOK) said Tuesday that the widening interest rate gap with the United States has deepened the challenge for South Korea’s monetary policy going forward.   Earlier this month, the U.S. Federal Reserve raised its benchmark rate by another 75 basis points to a target range of 3.75 … Read more

Yoon, China’s Xi hold 1st summit in Bali

BALI, Indonesia– President Yoon Suk-yeol held his first summit with Chinese President Xi Jinping in Bali on Tuesday, his office said, with North Korea expected to have been a key topic amid concern it could conduct another nuclear test.   The two leaders met on the sidelines of a Group of 20 summit, the presidential … Read more

S. Korean shares close higher on big-cap tech gains

SEOUL– South Korean stocks ended higher Tuesday, as a rise in big-cap tech shares offset profit-taking from recent sharp gains. The Korean won rose against the U.S. dollar.   After choppy trading, the benchmark Korea Composite Stock Price Index (KOSPI) added 5.68 points, or 0.23 percent, to close at 2,480.33.   Trading volume was moderate … Read more

Defender Kim Min-jae dismisses concerns over fatigue

DOHA– Having played the full 90 minutes in 20 out of Napoli’s 21 matches so far this season, South Korean defender Kim Min-jae has recently faced questions about his fatigue.   That he committed a rare gaffe in his own zone against Udinese Calcio over the weekend only fueled concerns that Kim was tiring at … Read more

VistaJet takes dining to new heights

VistaJet Private Dining The leading private aviation company redefines gastronomy in flight with expert scientific and artistic findings, signature seasonal menus and Michelin-starred partners London, November 15, 2022: At a table at 45,000 feet — higher than Mount Everest — is probably the highest you will ever dine. This is the unique experience offered by […]

Junshi Biosciences Announces Submission of a Marketing Authorization Application to the European Medicines Agency for Toripalimab

–The MAA was submitted in the EU for toripalimab seeking indications for the 1st line treatment of NPC and the 1st line treatment of ESCC — The global commercialization plan for toripalimab has expanded from China to the US and now, the EU SHANGHAI, China, Nov. 15, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., […]